Regeneron Completes Acquiring Sanofi's Stake In Libtayo

RTTNews | 670 dagar sedan
Regeneron Completes Acquiring Sanofi's Stake In Libtayo

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.

With today's closing, Regeneron will now record 100% of global net sales and expenses for Libtayo.

Regeneron intends to update its full year 2022 financial guidance to reflect the Libtayo purchase during its second quarter 2022 earnings announcement in early August.

On May 31, 2022, Regeneron announced that it had successfully acquired Checkmate Pharmaceuticals, Inc. for a total equity value of approximately $250 million.

As a result of the Checkmate acquisition, Regeneron expects to record in the second quarter of 2022 an acquired in-process research and development (IPR&D) charge of approximately $195 million, which would negatively impact GAAP and non-GAAP diluted earnings per share by approximately $1.70.

read more
Sanofi Q1 Profit Weak, But Sales Rise; Backs FY24 View; Stock Up

Sanofi Q1 Profit Weak, But Sales Rise; Backs FY24 View; Stock Up

French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq.
RTTNews | 6 dagar sedan
Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.
RTTNews | 89 dagar sedan
Sanofi Q3 Profit Rises, Backs FY23 View, To Split Consumer Healthcare Unit; Stock Dips

Sanofi Q3 Profit Rises, Backs FY23 View, To Split Consumer Healthcare Unit; Stock Dips

French drug major Sanofi reported Friday higher profit in its third quarter, while sales declined. Further, the company reiterated fiscal 2023 business earnings view. Separately, Sanofi said it plans to separate the Consumer Healthcare Business with a view to focus on Biopharma business. Sanofi shares were losing more than 15 percent in the morning trading in Paris.
RTTNews | 187 dagar sedan
Sanofi Q4 Profit Climbs, Sees Slower Earnings Growth In FY23; Stock Down

Sanofi Q4 Profit Climbs, Sees Slower Earnings Growth In FY23; Stock Down

French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
RTTNews | 453 dagar sedan
Asian Markets Trade Mixed After Fed Decision

Asian Markets Trade Mixed After Fed Decision

Asian stock markets are trading mixed on Thursday, following the mixed cues from Wall Street overnight, with the markets reacting to the US Fed's decision to hold interest rates steady, while also ruling out a rate hike in the near future. Asian Markets closed mostly lower on Wednesday.
RTTNews | 4h 35minuter sedan
Japanese Market Slightly Lower

Japanese Market Slightly Lower

Extending the losses in the previous session, the Japanese stock market is slightly lower on Thursday, following the mixed cues from Wall Street overnight. The Nikkei 225 is staying below the 38,300 level, with losses in index heavyweights and financial stocks.
RTTNews | 5h 6minuter sedan
Thai Shares May See Profit Taking On Thursday

Thai Shares May See Profit Taking On Thursday

Ahead of Wednesday's Labor Day holiday, the Thai stock market had moved higher in two straight sessions, collecting almost 10 points or 0.7 percent along the way. The Stock Exchange of Thailand now sits just above the 1,365-point plateau although it may open under pressure on Thursday.
RTTNews | 5h 31minuter sedan